title: Removable esophageal stents have poor efficacy for the treatment of refractory benign esophageal strictures (RBES).
abstract: With the recent availability of removable esophageal stents, endoscopic stenting has been utilized to treat refractory benign esophageal strictures (RBES). The objective of this study was to review the feasibility and effectiveness of removable esophageal stents to treat RBES. Patients who received removable esophageal stents for the treatment of RBES at the institution between 2004-2010 using its stent implantation logs and endoscopic database were retrospectively identified. Patient demographics, stricture etiology and location, stent and procedure characteristics, and clinical outcomes were obtained. Twenty-five patients with a mean age of 70 (72% male) underwent initial stent placement; 24 were successful. Overall clinical success was achieved in five of the 19 patients (26%) ultimately undergoing stent removal. RBES etiologies included anastomotic (13), radiation (5), peptic (3), chemotherapy (1), scleroderma (1), and unknown (2). Alimaxx-E (Merit-Endotek, South Jordan, UT, USA) stents were placed in 20 patients and Polyflex (Boston Scientific, Natick, MA, USA) stents were used in five patients. Immediate complications included failed deployment (1) and chest pain (7). Five patients died prior to stent removal. Stent migration was found in 53% (10/19) of patients who underwent stent removal: nine required additional therapy and one had symptom resolution. Out of the nine patients without stent migration, five required additional therapy and four had symptom resolution. Although placement of removable esophageal stents for RBES is technically feasible, it is frequently complicated by stent migration and chest pain. In addition, few patients achieved long-term stricture resolution after initial stenting. In this study, most patients ultimately required repeated stenting and/or dilations to maintain relief of dysphagia.
authors.affiliation: H.H. Chao Comprehensive Digestive Disease Center, Division of Gastroenterology, Department of Medicine, University of California, Irvine Medical Center, Orange, California, USA.
authors.forename: D T
authors.initials: DT
authors.lastname: Dan
authors.forename: B
authors.initials: B
authors.lastname: Gannavarapu
authors.forename: J G
authors.initials: JG
authors.lastname: Lee
authors.forename: K
authors.initials: K
authors.lastname: Chang
authors.forename: V R
authors.initials: VR
authors.lastname: Muthusamy
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002637:Chest Pain / Q000209:etiology; D003680:Deglutition Disorders / Q000209:etiology; D004106:Dilatation; D004940:Esophageal Stenosis / Q000150:complications / Q000628:therapy*; D004945:Esophagoscopy; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011475:Prosthesis Failure; D019233:Retreatment; D012189:Retrospective Studies; D015607:Stents / Q000009:adverse effects; D017211:Treatment Failure; D055815:Young Adult
keywords: SEPS; benign stricture; endoscopic stent; esophageal stricture